Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone

R. S. Stack; R. M. Califf; H. R. Phillips; D. B. Pryor; P. J. Quigley; R. P. Bauman; J. E. Tcheng; J. C. Greenfield

Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone

R. S. Stack, R. M. Califf, H. R. Phillips, D. B. Pryor, P. J. Quigley, R. P. Bauman, J. E. Tcheng, J. C. Greenfield

Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.

Original language	English (US)
Pages (from-to)	4F
Journal	American Journal of Cardiology
Volume	62
Issue number	10 PART II
State	Published - Jan 1 1988

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone'. Together they form a unique fingerprint.

Cite this

Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone. / Stack, R. S.; Califf, R. M.; Phillips, H. R.; Pryor, D. B.; Quigley, P. J.; Bauman, R. P.; Tcheng, J. E.; Greenfield, J. C.

In: American Journal of Cardiology, Vol. 62, No. 10 PART II, 01.01.1988, p. 4F.

Research output: Contribution to journal › Article › peer-review

@article{f56066ab83f54faea125d09ac017045d,

title = "Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone",

abstract = "Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.",

author = "Stack, {R. S.} and Califf, {R. M.} and Phillips, {H. R.} and Pryor, {D. B.} and Quigley, {P. J.} and Bauman, {R. P.} and Tcheng, {J. E.} and Greenfield, {J. C.}",

year = "1988",

month = jan,

day = "1",

language = "English (US)",

volume = "62",

pages = "4F",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "10 PART II",

}

TY - JOUR

T1 - Balloon angioplasty in acute myocardial infarction - Limitations of thrombolytic therapy when used alone

AU - Stack, R. S.

AU - Califf, R. M.

AU - Phillips, H. R.

AU - Pryor, D. B.

AU - Quigley, P. J.

AU - Bauman, R. P.

AU - Tcheng, J. E.

AU - Greenfield, J. C.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.

AB - Clinical perspective: Although thrombolytic therapy offers important, often life-preserving benefits to many AMI patients, its effectiveness is limited in several crucial respects: it does not achieve reperfusion in a substantial percentage of patients, nor does it reduce the underlying coronary lesion. In addition, its effectiveness cannot be predicted or reliably assessed by currently available noninvasive means in many AMI patients.

UR - http://www.scopus.com/inward/record.url?scp=0023681904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023681904&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0023681904

VL - 62

SP - 4F

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10 PART II

ER -